RX DRUG ACCESS PARTNERSHIP (EIN 571186937) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

AMY YARCICH

Phone

8042973173

Tax Period

2024-07-01 to 2025-06-30

RX DRUG ACCESS PARTNERSHIP, founded in 2003, is a small nonprofit in the Health Care sector that reported $518K in total revenue in fiscal year 2017. Revenue decreased 12% compared to the prior year.

Mission

RX PARTNERSHIP IS A PUBLIC/PRIVATE PARTNERSHIP WHICH EXISTS TO INCREASE ACCESS TO ESSENTIAL MEDICATION FOR VIRGINIA'S VULNERABLE POPULATIONS AND SERVE AS A RESOURCE TO THE ORGANIZATIONS THAT SUPPORT THESE POPULATIONS.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $656,497

Program Service Revenue $92,357

Investment Income $49,841

Other Revenue $5,400

TOTAL REVENUE $804,095

Expense Breakdown

Grants Paid $0

Salaries & Benefits $390,276

Fundraising Expenses $60,735

Program Expenses $643,787

Other Expenses $410,309

TOTAL EXPENSES $800,585

Year-over-Year Comparison

	2024	2023	Change
Revenue	$804,095	$845,043	0.0%
Expenses	$800,585	$803,294	0.0%
Net Income	$3,510	$41,749	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$172,409

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AMY YARCICH	EXECUTIVE DI	40.00	Officer	$154,269	$18,140	$172,409
SHAWN NELSON	CHAIR	1.00	Officer Director	$0	$0	$0
CHRISTINE BRYANT	CHAIR ELECT	1.00	Officer Director	$0	$0	$0
DINESH PAI	TREASURER	1.00	Officer Director	$0	$0	$0
LINDA HINES	SECRETARY	1.00	Officer Director	$0	$0	$0
DOURINA PETERSEN	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
DAVID EASTEP	DIRECTOR	1.00	Director	$0	$0	$0
MONIQUE FINNERAN	DIRECTOR	1.00	Director	$0	$0	$0
SARA HEISLER	DIRECTOR	1.00	Director	$0	$0	$0
JEN KOSTYNIUK	DIRECTOR	1.00	Director	$0	$0	$0
KATHLEEN LEWIS	DIRECTOR	1.00	Director	$0	$0	$0
KC OGBONNA	DIRECTOR	1.00	Director	$0	$0	$0
DOURINA PETERSEN	DIRECTOR	1.00	Director	$0	$0	$0
COREY PLEASANTS	DIRECTOR	1.00	Director	$0	$0	$0
YOGESH VERMA	DIRECTOR	1.00	Director	$0	$0	$0
CHARLIE WEBB	DIRECTOR	1.00	Director	$0	$0	$0
CAROLINE JURAN	EX-OFFICIO	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$804,095	$800,585	$1,606,168	$3,510
2024	$845,043	$803,294	$1,511,552	$41,749
2023	$746,153	$694,909	$1,342,893	$51,244
2022	$708,293	$671,456	$1,172,848	$36,837
2021	$727,629	$614,832	$1,221,862	$112,797
2020	$665,478	$573,771	$1,084,118	$91,707
2019	$605,677	$557,686	$909,172	$47,991
2018	$518,455	$523,266	$856,018	$-4,811

RX DRUG ACCESS PARTNERSHIP